OLD Category: Oncology

Immunologic alterations in the pancreatic cancer microenvironment of patients treated with neoadjuvant chemo- and radiotherapy

• Farren MR, Sayegh L, Ware MB, Chen HR, Gong J, Liang Y, Krasinskas A, Maithel SK, Zaidi M, Sarmiento JM, Kooby D, Patel P, El-Rayes B, Shaib W, Lesinski GB.

Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial

• Prat A et al.,

DNA methylation directs microRNA biogenesis in mammalian cells

• Glaich O et al.,

Prediction of survival of HPV16-negative, p16-negative oral cavity cancer patients using a 13-gene signature: A multicenter study using FFPE samples

• Chen C, Lohavanichbutr P, Zhang Y...Wolf G, Dort JC, Wang P

Pineoblastoma segregates into molecular sub-groups with distinct clinicopathologic features: A Rare Brain Tumor Consortium registry study

• Li BK, Vasiljevic A, Dufour C...Bouffet E, Huang A, Jouvet A

NF-kappa B Signaling-Related Signatures Are Connected with the Mesenchymal Phenotype of Circulating Tumor Cells in Non-Metastatic Breast Cancer

• Popeda M et al.,

A novel panel of differentially-expressed microRNAs in breast cancer brain metastasis may predict patient survival

• Giannoudis A et al.,

Prognostic Immune Cell Profiling of Malignant Pleural Effusion Patients by Computerized Immunohistochemical and Transcriptional Analysis

• Wu C et al.,

Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4

• Wang Z et al.,

Proteasome inhibition disrupts the metabolism of fumarate hydratase- deficient tumors by downregulating p62 and c-Myc

• Sourbier C et al.,

Deletion 20q12 is associated with histological transformation of nodal marginal zone lymphoma to diffuse large B-cell lymphoma

• Qian L et al.,

Endoscopic ultrasound may be used to deliver gene expression signatures using digital mRNA detection methods to immunophenotype pancreatic ductal adenocarcinoma to facilitate personalized immunotherapy

• Gleeson FC et al.,